NO333505B1 - 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt derav, og anvendelse derav for fremstilling av et medikament - Google Patents
4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt derav, og anvendelse derav for fremstilling av et medikament Download PDFInfo
- Publication number
- NO333505B1 NO333505B1 NO20055602A NO20055602A NO333505B1 NO 333505 B1 NO333505 B1 NO 333505B1 NO 20055602 A NO20055602 A NO 20055602A NO 20055602 A NO20055602 A NO 20055602A NO 333505 B1 NO333505 B1 NO 333505B1
- Authority
- NO
- Norway
- Prior art keywords
- tetrahydro
- trifluoromethyl
- compound
- ylidene
- benzoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003123032 | 2003-04-28 | ||
| JP2003401126 | 2003-12-01 | ||
| PCT/JP2004/005998 WO2004096775A1 (ja) | 2003-04-28 | 2004-04-26 | ４，４－ジフルオロ－１，２，３，４－テトラヒドロ－５ｈ－１－ベンゾアゼピン誘導体又はその塩 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20055602D0 NO20055602D0 (no) | 2005-11-25 |
| NO20055602L NO20055602L (no) | 2006-01-24 |
| NO333505B1 true NO333505B1 (no) | 2013-06-24 |
Family
ID=33422056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055602A NO333505B1 (no) | 2003-04-28 | 2005-11-25 | 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt derav, og anvendelse derav for fremstilling av et medikament |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7183271B2 (de) |
| EP (1) | EP1619185B1 (de) |
| KR (1) | KR100882154B1 (de) |
| AT (1) | ATE512951T1 (de) |
| AU (1) | AU2004234258B2 (de) |
| BR (1) | BRPI0409718A (de) |
| CA (1) | CA2521492C (de) |
| DK (1) | DK1619185T3 (de) |
| IL (1) | IL171332A (de) |
| MX (1) | MXPA05011521A (de) |
| NO (1) | NO333505B1 (de) |
| NZ (1) | NZ542815A (de) |
| PL (1) | PL1619185T3 (de) |
| PT (1) | PT1619185E (de) |
| RU (1) | RU2326868C2 (de) |
| SI (1) | SI1619185T1 (de) |
| WO (1) | WO2004096775A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| SI1619185T1 (sl) | 2003-04-28 | 2011-09-30 | Astellas Pharma Inc | 4,4-difluoro-1,2,3,4-tetrahidro-5H-1-benzazepinski derivat ali njegova sol |
| NZ565080A (en) | 2005-07-22 | 2011-03-31 | Mochida Pharm Co Ltd | Novel heterocyclidene acetamide derivative |
| AU2008283929B2 (en) | 2007-08-06 | 2013-10-10 | Serenity Pharmaceuticals, Llc | Methods and devices for desmopressin drug delivery |
| PL2712622T3 (pl) * | 2008-05-21 | 2017-01-31 | Ferring B.V. | Ulegająca rozpadowi w ustach desmopresyna do zwiększania początkowego okresu snu niezakłócanego przez nokturię |
| US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
| US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
| DK2860175T3 (da) * | 2012-06-11 | 2018-01-29 | Tacurion | Fremgangsmåde til fremstilling af 4,4,7-trifluor-1,2,3,4-tetrahydro-5h-1-benzazepin-forbindelse og intermediat til syntese deraf |
| WO2018011681A1 (en) | 2016-07-14 | 2018-01-18 | Pfizer Inc. | Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2137760C1 (ru) * | 1993-08-26 | 1999-09-20 | Яманоути Фармасьютикал Ко., Лтд. | Производное бензазепина, фармацевтическая композиция, производное дифторбензазепина и производное (замещенного) аминобензоилдифторбензазепина |
| JP3215910B2 (ja) | 1994-06-15 | 2001-10-09 | 大塚製薬株式会社 | ベンゾヘテロ環誘導体 |
| JPH11349570A (ja) | 1994-06-15 | 1999-12-21 | Otsuka Pharmaceut Co Ltd | ベンゾヘテロ環誘導体 |
| ES2284741T3 (es) | 1994-06-15 | 2007-11-16 | Otsuka Pharmaceutical Company, Limited | Derivados de benzoheterociclicos utilizados como moduladores de vasoprsinao de oxitocina. |
| TW359669B (en) * | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
| JPH09221476A (ja) | 1995-12-15 | 1997-08-26 | Otsuka Pharmaceut Co Ltd | 医薬組成物 |
| JPH09221475A (ja) | 1996-02-13 | 1997-08-26 | Yamanouchi Pharmaceut Co Ltd | 新規なオキシム誘導体 |
| AR011913A1 (es) * | 1997-03-06 | 2000-09-13 | Yamano Masaki | Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos. |
| JP2926335B2 (ja) | 1997-06-13 | 1999-07-28 | 大塚製薬株式会社 | 医薬組成物 |
| AU8592598A (en) | 1997-07-30 | 1999-02-22 | Wyeth | Tricyclic vasopressin agonists |
| BR9811585A (pt) | 1997-07-30 | 2000-09-26 | American Home Prod | Agonistas de vasopressinas tricìclicas |
| US6547395B1 (en) * | 1998-02-06 | 2003-04-15 | Wavefront Sciences, Inc. | Methods of measuring moving objects and reducing exposure during wavefront measurements |
| DE60001054T2 (de) | 1999-02-04 | 2003-07-24 | Wyeth, Madison | Trizyclische pyridin n-oxide vasopressin agonisten |
| GB0000079D0 (en) * | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| HUP0402235A2 (hu) | 2001-11-16 | 2005-02-28 | Yamanouchi Pharmaceutical Co., Ltd. | 4,4-Difluor-1,2,3,4-tetrahidro-5H-1-benzazepin-származékok és ezek sói és ezeket tartalmazó gyógyszerkészítmények |
| SI1619185T1 (sl) | 2003-04-28 | 2011-09-30 | Astellas Pharma Inc | 4,4-difluoro-1,2,3,4-tetrahidro-5H-1-benzazepinski derivat ali njegova sol |
-
2004
- 2004-04-26 SI SI200431724T patent/SI1619185T1/sl unknown
- 2004-04-26 DK DK04729502.7T patent/DK1619185T3/da active
- 2004-04-26 US US10/554,150 patent/US7183271B2/en not_active Expired - Lifetime
- 2004-04-26 KR KR1020057020359A patent/KR100882154B1/ko not_active Expired - Fee Related
- 2004-04-26 CA CA2521492A patent/CA2521492C/en not_active Expired - Fee Related
- 2004-04-26 WO PCT/JP2004/005998 patent/WO2004096775A1/ja not_active Ceased
- 2004-04-26 BR BRPI0409718-1A patent/BRPI0409718A/pt not_active IP Right Cessation
- 2004-04-26 AU AU2004234258A patent/AU2004234258B2/en not_active Ceased
- 2004-04-26 RU RU2005136863/04A patent/RU2326868C2/ru not_active IP Right Cessation
- 2004-04-26 MX MXPA05011521A patent/MXPA05011521A/es active IP Right Grant
- 2004-04-26 NZ NZ542815A patent/NZ542815A/en not_active IP Right Cessation
- 2004-04-26 AT AT04729502T patent/ATE512951T1/de active
- 2004-04-26 EP EP04729502A patent/EP1619185B1/de not_active Expired - Lifetime
- 2004-04-26 PT PT04729502T patent/PT1619185E/pt unknown
- 2004-04-26 PL PL04729502T patent/PL1619185T3/pl unknown
-
2005
- 2005-10-10 IL IL171332A patent/IL171332A/en active IP Right Grant
- 2005-11-25 NO NO20055602A patent/NO333505B1/no not_active IP Right Cessation
-
2006
- 2006-11-14 US US11/598,732 patent/US7807664B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US7807664B2 (en) | 2010-10-05 |
| EP1619185A1 (de) | 2006-01-25 |
| US20060122170A1 (en) | 2006-06-08 |
| PL1619185T3 (pl) | 2011-12-30 |
| CA2521492A1 (en) | 2004-11-11 |
| US20070167429A1 (en) | 2007-07-19 |
| AU2004234258A1 (en) | 2004-11-11 |
| IL171332A (en) | 2011-03-31 |
| KR20060007402A (ko) | 2006-01-24 |
| PT1619185E (pt) | 2011-08-25 |
| BRPI0409718A (pt) | 2006-05-02 |
| EP1619185B1 (de) | 2011-06-15 |
| EP1619185A4 (de) | 2008-07-23 |
| NO20055602D0 (no) | 2005-11-25 |
| RU2005136863A (ru) | 2006-04-20 |
| RU2326868C2 (ru) | 2008-06-20 |
| DK1619185T3 (da) | 2011-07-18 |
| WO2004096775A1 (ja) | 2004-11-11 |
| NO20055602L (no) | 2006-01-24 |
| SI1619185T1 (sl) | 2011-09-30 |
| US7183271B2 (en) | 2007-02-27 |
| KR100882154B1 (ko) | 2009-02-06 |
| MXPA05011521A (es) | 2006-01-23 |
| AU2004234258B2 (en) | 2009-04-09 |
| NZ542815A (en) | 2009-01-31 |
| CA2521492C (en) | 2010-09-21 |
| ATE512951T1 (de) | 2011-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2351471T3 (es) | Nueva sal y polimorfo de inhibidores de dpp-iv. | |
| KR100632882B1 (ko) | 4, 4-디플루오로-1, 2, 3,4-테트라하이드로-5ｈ-1-벤즈아제핀 유도체 또는 그 염 | |
| KR101047211B1 (ko) | 인자 ｘａ 억제제로서의 신규 사이클로알케인카복스아마이드 | |
| RU2559325C2 (ru) | Соли 4-[2-[[5-метил-1-(2-нафталинил)-1н-пиразол-3-ил]окси]этил]морфолина | |
| WO2008059854A1 (en) | Piperidine derivatives or salts thereof | |
| BRPI0719650A2 (pt) | Derivados de azabiciclo-octano, método de fabricação deles e usos dos mesmos como inibidores de dipeptidil peptidade iv | |
| TW200901968A (en) | Atrope isomers of pyrrole derivatives | |
| CN101014578A (zh) | 三唑衍生物或其盐 | |
| NO333505B1 (no) | 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt derav, og anvendelse derav for fremstilling av et medikament | |
| JP2008214224A (ja) | チアゾリルスルホニルアミド化合物 | |
| JP4765545B2 (ja) | ベンゾアゼピン誘導体を有効成分とする医薬組成物 | |
| JP4334403B2 (ja) | ４，４−ジフルオロ−１，２，３，４−テトラヒドロ−５ｈ−１−ベンゾアゼピン誘導体又はその塩 | |
| ES2366641T3 (es) | Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o sal del mismo. | |
| JP4765546B2 (ja) | ベンゾアゼピン誘導体又はその塩の製造法 | |
| KR20150129698A (ko) | 피롤리딘-3-일 아세트산 유도체의 염 및 그의 결정 | |
| BRPI0620526A2 (pt) | sal de acetato e método para alcançar um efeito em um paciente | |
| BRPI0409718B1 (pt) | Derivative of 4,4-difluor-1,2,3,4-tetraidro-5h-1-benzazepine or its salt | |
| JPH04308586A (ja) | ベンゾピラン誘導体 | |
| HK40096710A (zh) | 用於治疗红细胞障碍和炎性疾病的四氢异喹啉衍生物 | |
| JPH04356466A (ja) | 新規キノリン誘導体及びそれを有効成分として含有する制癌剤効果増強剤 | |
| EP2315762A2 (de) | Fluorsubstituierte 3,4-diaryl-4,5-dihydro-1h-pyrazol-1- carbonsäureamidinderivate mit cb1-antagonistischer wirkung | |
| ZA200403189B (en) | 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives or salts thereof. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |